Novosibirsk: Vector Vaccine Vector reached the second stage of testing
The Novosibirsk Center for Virology and Biotechnology "Vector" began the second stage of testing the vaccine against the Covid-19, said Anna Popova, head of Rospotrebnadzor. "Today, clinical trials are being conducted, all volunteers who have been selected in a special way are good. Those who are introduced by the vaccine have no reactions, there are not even cases of the slightest redness at the place of administration," Popova said .